Evidence map›Paper›PMID 41834361›Full record

ArticleHealth expectations : an international journal of public participation in health care and health policy2026

Recommendations to Improve Healthcare Service Provision for Cognitive Impairment in People With Parkinson's Disease: A Mixed Methods Study of the Lived Experience Expert Perspective.

Deepa Sriram, Dana Pourzinal, Daniel X Bailey, Deborah Brooks, Kirstine Shrubsole, Jihyun Yang, Neil Page, Emily McCann, Elton H Lobo, James M King and 3 more

Abstract read
In one paragraph

Article in Health expectations : an international journal of public participation in health care and health policy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Guideline
  2. Article
  3. What can we do to enhance cognitive care in Parkinson's disease?Alzheimer's & dementia (Amsterdam, Netherlands)
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Deepa SriramUQ Centre for Clinical Research, The University of Queensland, Herston, Queensland, Australia.ORCID 0000-0003-4390-6796
Dana PourzinalUQ Centre for Clinical Research, The University of Queensland, Herston, Queensland, Australia.
Daniel X BaileyCentre for Health Services Research, The University of Queensland, Herston, Queensland, Australia.
Deborah BrooksUQ Centre for Clinical Research, The University of Queensland, Herston, Queensland, Australia.ORCID 0000-0003-4902-0654
Kirstine ShrubsoleQueensland Aphasia Research Centre, The University of Queensland, Brisbane, Queensland, Australia.
Jihyun YangUQ Centre for Clinical Research, The University of Queensland, Herston, Queensland, Australia.
Neil PageUQ Centre for Clinical Research, The University of Queensland, Herston, Queensland, Australia.
Emily McCannUQ Centre for Clinical Research, The University of Queensland, Herston, Queensland, Australia.ORCID 0000-0002-7703-9419
Elton H LoboUQ Centre for Clinical Research, The University of Queensland, Herston, Queensland, Australia.ORCID 0000-0003-0096-6318
James M KingUQ Centre for Clinical Research, The University of Queensland, Herston, Queensland, Australia.
Leander K MitchellSchool of Psychology, The University of Queensland, Brisbane, Queensland, Australia.
Nancy A PachanaSchool of Psychology, The University of Queensland, Brisbane, Queensland, Australia.
Nadeeka N DissanayakaUQ Centre for Clinical Research, The University of Queensland, Herston, Queensland, Australia.

Funding

The Australian Government National Health and Medical Research Centre (NHMRC) Medical Research Future Fund (MRFF) Dementia Aging and Aged Care Mission Grant 2022 2022002774
6 · The paper itself

Abstract

backgroundCognitive impairment, including dementia, is one of the most important nonmotor symptoms of Parkinson's disease (PD). It lowers quality of life and impacts health and economic outcomes for individuals living with PD, their families, and society. Poor recognition and management of cognitive impairment and dementia in PD highlights the need for improved diagnostic and postdiagnostic care pathways. We aimed to inquire about current health services for cognitive evaluation in Australia from people with lived experience of PD. The objective was to derive recommendations for best practice guidelines.

methodsThis two-stage exploratory sequential mixed-method study utilised qualitative and quantitative methods. Stage 1 conducted seven online focus groups exploring the experiences of neuropsychological assessment, diagnosis, and post-diagnostic support for cognitive impairment and dementia in PD. Transcripts were analysed using deductive and inductive thematic analysis and recommendations were derived from this data. Stage 2 involved a national survey of these recommendations to ascertain agreement using a 5-point Likert scale. Recommendations meeting ≥ 70% agreement, median rating ≥ 4, and inter quartile rating (IQR) ≤ 1 were deemed acceptable for inclusion in the guidelines.

resultsFocus groups included people with PD (PwPD) with subjective cognitive decline (PD-SCD, n = 6), mild cognitive impairment (PD-MCI, n = 3), dementia (PDD, n = 3), and carers (n = 3). Findings resulted in the formulation of 25 recommendations from four overarching categories and with several inter-related themes: (1) Pre-assessment (clinicians' reluctance to assess; referrals; informed choice), (2) assessment (delivery of assessment; telehealth), (3) diagnosis (need for transparency; focused discussion; time to discuss), and (4) postdiagnostic care (follow-up assessment; information in plain language; advocating for PwPD). The national survey (n = 69 PwPD, n = 12 carers) found that all recommendations except one demonstrated high agreement (≥ 88%, median rating ≥ 4, IQR ≤ 1). Delivery of a cognitive diagnosis on the same day as cognitive testing was the only area that did not achieve consensus.

conclusionWe identified critical gaps in the diagnosis and management of cognitive symptoms within clinical services, and the subsequent implications for PwPD and their carers. These results provide a lived experience perspective to the development of best practice guidelines for cognitive evaluation in PD. PUBLIC CONTRIBUTION: The project was endorsed by our Consumer and Community Involvement Group (CCIG), a research advisory board consisting of people with lived experience of Parkinson's Disease and dementia, including those caring for PwPD. The CCIG identified initial need for the research project, were involved in refining the focus group topic guide and refining the recommendations for the national survey.

Indexed as

Cognitive DysfunctionParkinson DiseaseAgedAged, 80 and overAustraliaDementiaFemaleFocus GroupsHumansMaleMiddle AgedNeuropsychological TestsPractice Guidelines as TopicQualitative ResearchQuality of Life

Identifiers

PMID41834361
PMCPMC13080892

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.